Odds ratios of peripheral neuropathy for one year preceding the index date exposure to statins and fibrates within four gender and age categories. Province of Varese, Italy, 1997–1999.
| Cases | Controls | OR† | (95% CI) | |
|---|---|---|---|---|
| Number (%) | Number (%) | |||
| †Odds ratios and 95 % confidence intervals. Estimates are adjusted for the presence of thyroid disease, diabetes, anaemia, chronic renal failure, and connective tissue disease. *p<0.05. | ||||
| Men aged less than 60 years | ||||
| Statins | 9 (3.24) | 151(2.87) | 1.17 | (0.57 to 2.38) |
| Fibrates | 5 (1.80) | 68 (1.29) | 1.16 | (0.44 to 3.02) |
| Women aged less than 60 years | ||||
| Statins | 21 (2.62) | 327 (2.21) | 1.20 | (0.76 to 1.91) |
| Fibrates | 5 (0.62) | 66 (0.45) | 1.19 | (0.47, 3.02) |
| Men aged more than 60 years | ||||
| Statins | 20 (5.88) | 258 (5.05) | 1.13 | (0.70 to 1.84) |
| Fibrates | 8 (2.35) | 72 (1.41) | 1.41 | (0.65 to 3.06) |
| Women aged more than 60 years | ||||
| Statins | 45 (7.26) | 611 (5.62) | 1.28 | (0.92 to 1.76) |
| Fibrates | 15 (2.42) | 133 (1.22) | 1.90* | (1.08 to 3.31) |